Workflow
AI+脑科学
icon
Search documents
王腾新公司成立14天获数千万融资,资方阵容强大但没小米
Xin Lang Cai Jing· 2026-01-20 09:38
Core Viewpoint - Wang Teng, former General Manager of Xiaomi's China Marketing Department, has founded a new company named "Today Yixiu," focusing on sleep health products, and has recently completed a seed round financing of several tens of millions of yuan [1][8]. Company Overview - "Today Yixiu" aims to develop products related to sleep health, targeting over 300 million people in China suffering from sleep disorders [5][12]. - The company was established on January 6, 2026, and secured financing within 14 days, indicating strong interest in the startup within the investment community [5][12]. Financing Details - The seed round financing was led by investors including GL Ventures, Zhiyuan Robotics, Xilinmen, and Yunjiu Capital [1][8]. - The total scale of the financing is reported to be several tens of millions of yuan [1][8]. Team and Operations - The initial team consists of members primarily from leading tech companies such as Xiaomi and Huawei [3][10]. - The company plans to maintain competitive salary levels and benefits similar to large tech firms, with a focus on stock incentives [5][12]. - The headquarters is located in Beijing, with potential plans to establish branches in Shenzhen and Hangzhou in the future [5][12]. Product Development - "Today Yixiu" will leverage AI and brain science technology to provide a closed-loop solution for sleep monitoring, intervention, and energy management, differentiating itself from traditional sleep aid hardware [5][12].
国内首款VR学习力训练机上市,虚之实科技用AI+脑科学破解青少年学习困难难题
Jiang Nan Shi Bao· 2025-09-16 11:08
Core Insights - The article highlights the launch of the "Xinning Zhijing Youth Learning Ability Training Machine" by Xu Zhi Shi Technology, aimed at addressing the learning challenges faced by adolescents in China, particularly focusing on enhancing their learning and emotional regulation abilities. Group 1: Product Overview - The product is based on a VR cognitive training system that has undergone seven years of clinical validation, bringing digital therapy used in top hospitals into the home environment [1][5]. - It targets three main issues faced by modern adolescents: difficulty in learning, emotional control, and knowledge retention [1]. Group 2: Educational Challenges - Parents in China are increasingly concerned about their children's low learning efficiency, emotional volatility, and lack of self-control, with traditional tutoring methods proving insufficient [2]. - Data indicates that while daily study time for middle school students has increased to 4.6 hours, knowledge retention remains low at only 52% [3]. - The demand for psychological consultations among adolescents aged 12-16 has surged by 170% over three years, with 68% of cases linked to academic pressure [3]. Group 3: Training Methodology - The training program incorporates VR immersive training and AI personalized algorithms, requiring only 15-20 minutes of daily use to enhance children's learning and emotional capabilities [3]. - It covers six dimensions: memory, executive function, attention, stress resistance, emotional stability, and self-control, and includes a "Heart Power Supply Station" for immediate stress relief and emotional regulation [3]. Group 4: Effectiveness and Validation - The product features various VR training scenarios and utilizes EEG and eye-tracking data for dual assessment, employing mindfulness breathing and biofeedback techniques to improve foundational skills through gameplay [4]. - Clinical trials with over 300 adolescents showed improvements in learning focus and emotional regulation by 27-60%, with sustained use of 3-6 months leading to growth in multiple brain-related capabilities [4]. Group 5: Company Background and Market Expansion - Xu Zhi Shi Technology is a pioneer in the VR treatment of chronic brain diseases, having received seven medical device registrations, including EU CE and UK MHRA approvals, and serving over 400 hospitals nationwide [5]. - The launch of Xinning Zhijing marks the company's expansion from B2B medical applications to the C2C family market, aiming to make advanced brain science accessible to more families [5]. - The company plans to continuously update its C-end products and expand its offerings to different demographics, including elderly and middle-aged individuals [5].